Vimarsana
Biggest News Aggregation in the World

Arvind Bothra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arvind Bothra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arvind Bothra Today - Breaking & Trending Today

MP: Two College Students In Police Net For Loot Attempt In Mandsaur - Vimarsana News

MP: Two College Students In Police Net For Loot Attempt In Mandsaur

Mandsaur SP Anurag Sujania informed that an incident was reported on June 6, where two persons attempted to snatch a bag containing Rs 20 lakh from a mandi trader by putting chilli powder in his eyes.

Aurobindo Pharma appoints Arvind Bothra as Senior VP, Head of Investor Relations and Corp Comm - Vimarsana News

Aurobindo Pharma appoints Arvind Bothra as Senior VP, Head of Investor Relations and Corp Comm

Aurobindo Pharma appoints Arvind Bothra as Senior VP, Head of Investor Relations and Corp Comm Aurobindo Pharma appoints Arvind Bothra as Senior VP, Head of Investor Relations and Corp Comm 31 May 2021 | News linkedin.com Arvind Bothra has joined Aurobindo Pharma as Senior Vice President, Head of Investor Relations and Corporate Communications and will be closely working with the leadership team. Says Bothra, "I look forward to work with my amazing new colleagues at Aurobindo and make a difference." Bothra is a finance professional with a proven record of establishing cross-functional partne...

Lupin Announces Partnership with Phil, Inc. in Support of SOLOSEC® (secnidazole) - Vimarsana News

Lupin Announces Partnership with Phil, Inc. in Support of SOLOSEC® (secnidazole)

Share this article Share this article MUMBAI, India and BALTIMORE, Feb. 1, 2021 /PRNewswire/ -- Lupin Pharmaceuticals Inc. (Lupin), global pharmaceutical company, announced today a partnership with Phil, Inc., which helps deliver cost-effective next-generation access solutions for patients who are prescribed Solosec® (secnidazole) 2g oral granules for the treatment of bacterial vaginosis (BV) in adult women. Solosec® is the only single 2g oral dose therapy for the most common vaginal infection in the U.S. among adult women. This treatment is designed to deliver a full course of therapy in...